With obesity and raised insulin levels there is also a decrease in IGFBP-1 and IGFBP-2 levels and these reductions could potentially result in an increase IGF-availability in tissues (110). The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.